Showing results (291-300 of 366) with videos related to
Sort By:
Pageof 37
Nature|March 4, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancerAnton Safonov, Minna Lee, David N Brown, et al.Human Genetics|August 28, 2012
A genome-wide association study of breast cancer in women of African ancestryFang Chen, Gary K Chen, Daniel O Stram, et al.Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.Human Molecular Genetics|May 13, 2022
Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approachGuimin Gao, Fangyuan Zhao, Thomas U Ahearn, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.The New England Journal of Medicine|January 20, 2021
A Population-Based Study of Genes Previously Implicated in Breast CancerChunling Hu, Steven N Hart, Rohan Gnanaolivu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersChristoph Engel, Beatrix Versmold, Barbara Wappenschmidt, et al.NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.Pageof 37